nodes	percent_of_prediction	percent_of_DWPC	metapath
Betahistine—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0228	0.195	CcSEcCtD
Betahistine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00719	0.0616	CcSEcCtD
Betahistine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00685	0.0587	CcSEcCtD
Betahistine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00492	0.0422	CcSEcCtD
Betahistine—Flatulence—Metformin—polycystic ovary syndrome	0.00467	0.04	CcSEcCtD
Betahistine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.0044	0.0377	CcSEcCtD
Betahistine—Malaise—Metformin—polycystic ovary syndrome	0.00427	0.0367	CcSEcCtD
Betahistine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00401	0.0344	CcSEcCtD
Betahistine—Discomfort—Metformin—polycystic ovary syndrome	0.00399	0.0342	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00397	0.00449	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.00395	0.00447	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00395	0.00447	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00387	0.00438	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00387	0.00438	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00385	0.00436	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.00384	0.00434	CbGpPWpGaD
Betahistine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00379	0.0325	CcSEcCtD
Betahistine—Skin disorder—Metformin—polycystic ovary syndrome	0.00376	0.0322	CcSEcCtD
Betahistine—HRH1—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.00373	0.00423	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00367	0.00416	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00365	0.00413	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00365	0.00413	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00359	0.00406	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00356	0.00403	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.00354	0.004	CbGpPWpGaD
Betahistine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00345	0.0296	CcSEcCtD
Betahistine—HRH3—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00344	0.0039	CbGpPWpGaD
Betahistine—Somnolence—Metformin—polycystic ovary syndrome	0.00344	0.0295	CcSEcCtD
Betahistine—HRH3—G alpha (i) signalling events—GNAS—polycystic ovary syndrome	0.00344	0.00389	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.00343	0.00389	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00341	0.00386	CbGpPWpGaD
Betahistine—Dyspepsia—Metformin—polycystic ovary syndrome	0.0034	0.0292	CcSEcCtD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00335	0.0038	CbGpPWpGaD
Betahistine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00334	0.0286	CcSEcCtD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.00334	0.00378	CbGpPWpGaD
Betahistine—Fatigue—Metformin—polycystic ovary syndrome	0.00333	0.0286	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00331	0.00375	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00331	0.00375	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00331	0.00375	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00327	0.0037	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00327	0.0037	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00322	0.00365	CbGpPWpGaD
Betahistine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00319	0.0273	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.0031	0.00351	CbGpPWpGaD
Betahistine—Urticaria—Metformin—polycystic ovary syndrome	0.00307	0.0264	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00306	0.00346	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00301	0.0034	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00297	0.00336	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—IRS2—polycystic ovary syndrome	0.00295	0.00334	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00295	0.00334	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00293	0.00332	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00292	0.00331	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.00289	0.00327	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.00283	0.0032	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.0028	0.00317	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.0028	0.00317	CbGpPWpGaD
Betahistine—Asthenia—Metformin—polycystic ovary syndrome	0.00278	0.0238	CcSEcCtD
Betahistine—Pruritus—Metformin—polycystic ovary syndrome	0.00274	0.0235	CcSEcCtD
Betahistine—HRH3—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00271	0.00307	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00268	0.00304	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00267	0.00302	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00266	0.00301	CbGpPWpGaD
Betahistine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00265	0.0227	CcSEcCtD
Betahistine—HRH1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00263	0.00298	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00262	0.00296	CbGpPWpGaD
Betahistine—HRH1—IL-4 Signaling Pathway—IRS1—polycystic ovary syndrome	0.00258	0.00292	CbGpPWpGaD
Betahistine—Dizziness—Metformin—polycystic ovary syndrome	0.00256	0.0219	CcSEcCtD
Betahistine—HRH1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00255	0.00289	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.00254	0.00288	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00253	0.00286	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00247	0.0028	CbGpPWpGaD
Betahistine—Vomiting—Metformin—polycystic ovary syndrome	0.00246	0.0211	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00244	0.00276	CbGpPWpGaD
Betahistine—Rash—Metformin—polycystic ovary syndrome	0.00244	0.0209	CcSEcCtD
Betahistine—Dermatitis—Metformin—polycystic ovary syndrome	0.00244	0.0209	CcSEcCtD
Betahistine—HRH3—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00242	0.00274	CbGpPWpGaD
Betahistine—Headache—Metformin—polycystic ovary syndrome	0.00242	0.0208	CcSEcCtD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00239	0.00271	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00235	0.00266	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00235	0.00266	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NPB—polycystic ovary syndrome	0.00234	0.00265	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00232	0.00263	CbGpPWpGaD
Betahistine—HRH3—G alpha (i) signalling events—POMC—polycystic ovary syndrome	0.00232	0.00262	CbGpPWpGaD
Betahistine—Nausea—Metformin—polycystic ovary syndrome	0.0023	0.0197	CcSEcCtD
Betahistine—HRH3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00227	0.00257	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00225	0.00254	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00222	0.00251	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00219	0.00248	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00218	0.00246	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00213	0.00242	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00213	0.00241	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00213	0.00241	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00212	0.0024	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00211	0.00239	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00211	0.00238	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00208	0.00236	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00208	0.00235	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00206	0.00233	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00205	0.00232	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00199	0.00226	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00198	0.00224	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00196	0.00221	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00196	0.00221	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00194	0.00219	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00188	0.00213	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00188	0.00213	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00187	0.00212	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00186	0.00211	CbGpPWpGaD
Betahistine—HRH3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00184	0.00208	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00183	0.00207	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.0018	0.00204	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00178	0.00202	CbGpPWpGaD
Betahistine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00178	0.00201	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00178	0.00201	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00174	0.00197	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00173	0.00196	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00168	0.00191	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.00159	0.0018	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00159	0.0018	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00157	0.00178	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00156	0.00177	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00153	0.00174	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00144	0.00163	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.00143	0.00162	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00143	0.00162	CbGpPWpGaD
Betahistine—HRH3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.0014	0.00159	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00139	0.00158	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00137	0.00155	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00136	0.00154	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00135	0.00152	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00133	0.0015	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00131	0.00148	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00131	0.00148	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00131	0.00148	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00128	0.00145	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00128	0.00145	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FST—polycystic ovary syndrome	0.00128	0.00144	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00127	0.00144	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.00127	0.00144	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00126	0.00143	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LHB—polycystic ovary syndrome	0.00125	0.00141	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.00122	0.00138	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00121	0.00137	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0012	0.00136	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0012	0.00136	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00119	0.00134	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00118	0.00133	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00118	0.00133	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00118	0.00133	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SCT—polycystic ovary syndrome	0.00117	0.00132	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00115	0.0013	CbGpPWpGaD
Betahistine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00114	0.00129	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00113	0.00128	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00111	0.00126	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.00109	0.00124	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00109	0.00124	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00109	0.00124	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00109	0.00124	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00108	0.00123	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.00107	0.00121	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00106	0.0012	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00102	0.00116	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00101	0.00115	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000999	0.00113	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000993	0.00112	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.000974	0.0011	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000968	0.0011	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000966	0.00109	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000955	0.00108	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000908	0.00103	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000896	0.00101	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000893	0.00101	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.000886	0.001	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000884	0.001	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.000882	0.000998	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.000879	0.000995	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000822	0.000931	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000822	0.000931	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.000806	0.000913	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.000801	0.000906	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000792	0.000897	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000784	0.000888	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000776	0.000879	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000774	0.000876	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000767	0.000868	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000765	0.000866	CbGpPWpGaD
Betahistine—HRH3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000761	0.000862	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00075	0.000849	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000742	0.00084	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000732	0.000829	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000724	0.000819	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000719	0.000814	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000719	0.000814	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000717	0.000812	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000705	0.000798	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.0007	0.000793	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000696	0.000788	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000691	0.000783	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000688	0.000779	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000686	0.000776	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000681	0.000771	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000681	0.00077	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000653	0.000739	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000646	0.000731	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000646	0.000731	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000631	0.000714	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000623	0.000705	CbGpPWpGaD
Betahistine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000608	0.000688	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000604	0.000684	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000601	0.000681	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00059	0.000668	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000587	0.000664	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000571	0.000646	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000556	0.00063	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000519	0.000588	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000506	0.000573	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000505	0.000572	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—LEP—polycystic ovary syndrome	0.000495	0.00056	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000473	0.000535	CbGpPWpGaD
Betahistine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000463	0.000524	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00046	0.000521	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000445	0.000503	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000441	0.0005	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000433	0.00049	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—POMC—polycystic ovary syndrome	0.000425	0.000481	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—INS—polycystic ovary syndrome	0.000423	0.000478	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000422	0.000477	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000419	0.000474	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000416	0.000471	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000411	0.000466	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000409	0.000463	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000408	0.000462	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000402	0.000455	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000389	0.000441	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000389	0.00044	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000388	0.000439	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000386	0.000436	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000381	0.000431	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000368	0.000416	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000361	0.000409	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000358	0.000406	CbGpPWpGaD
Betahistine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000357	0.000404	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000353	0.0004	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000335	0.000379	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.00033	0.000374	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000316	0.000357	CbGpPWpGaD
Betahistine—HRH3—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000313	0.000354	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.0003	0.000339	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000295	0.000334	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000292	0.000331	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000272	0.000307	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000272	0.000307	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000267	0.000302	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000262	0.000296	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000259	0.000293	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000253	0.000286	CbGpPWpGaD
Betahistine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000252	0.000285	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000239	0.000271	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000238	0.000269	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000237	0.000268	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000228	0.000259	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000225	0.000255	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000208	0.000236	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000199	0.000225	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000195	0.000221	CbGpPWpGaD
Betahistine—HRH3—Signaling Pathways—IL6—polycystic ovary syndrome	0.000185	0.000209	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000167	0.000189	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000163	0.000185	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000146	0.000165	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	0.00014	0.000159	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	0.00014	0.000158	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000135	0.000153	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000135	0.000153	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000128	0.000145	CbGpPWpGaD
Betahistine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000103	0.000117	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.82e-05	9.98e-05	CbGpPWpGaD
Betahistine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	6.1e-05	6.91e-05	CbGpPWpGaD
